Ongoing studies confirm that infantile-onset NCL (due to mutated CLN1 and CLN10 genes) and classical CLN2 disease have the next most rapidly severe course and shortest survival. The gene discussed is PPT1; the disease is neuronal ceroid lipofuscinosis.